HALI MCDONALD: Open Payments
NPI 1104310721 · GARDENDALE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$480 in 31 payments from 9 companies in 2025. Trend: 2023 $463 · 2024 $414 · 2025 $480
Food & beverage: $480
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 11 | $178 |
| Boston Scientific Corporation | 13 | $152 |
| Janssen Biotech, Inc. | 1 | $28 |
| ABBVIE INC. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| SCILEX PHARMACEUTICALS INC. | 1 | $21 |
| Averitas Pharma Inc. | 1 | $18 |
| Abbott Laboratories | 1 | $17 |
| Novo Nordisk Inc | 1 | $17 |
Products named: XTAMPZA, WaveWriter Alpha Prime 16, TECVAYLI, BOTOX, NINLARO, ZTLido, QUTENZA, PROCLAIM.
Industry payments across AL — which companies pay providers there.
